miR-200a, a family of tumor suppressor miRNAs, is downregulated in TNBC and maintains a stable epithelial phenotype by directly targeting the E-cadherin repressors ZEB1 and ZEB2, thereby significantly inhibiting EMT and metastasis (53). The gene discussed is ZEB2; the disease is neoplasm.